Swiss court confirms that Semenya cannot compete without hormone suppressant treatment



[ad_1]

Semenya was banned from defending her 800-meter Olympics title because she refused to abide by the testosterone regulations set out by the World Athletics governing body.

Caster Semenya competes in the women’s 800 meters during the IAAF Diamond League competition on May 3, 2019 in Doha. Image: AFP

LAUSANNE, Switzerland – The Swiss Supreme Court upheld a ruling Tuesday that South Africa’s double 800m Olympic champion, Caster Semenya, cannot compete until she agrees to be treated with hormone suppressing drugs.

“After many months of deliberation, the Swiss Federal Supreme Court has refused to overturn a 2019 ruling against Olympic gold medalist Caster Semenya by the Court of Arbitration for Sport (CAS),” the court said in a statement.

“The Swiss Supreme Court determined that the requirement of World Athletics to subject certain athletes to surgical or pharmacological interventions as a precondition for competing in women’s events from 400 to 1,500 m does not constitute a violation of Swiss public policy,” the court added.

WATCH: 2019 and off-piste year for Semenya

In 2019, the Council of the International Association of Athletics Federations (IAAF), which met in Doha, approved rules requiring the concentration of testosterone in a female transgender athlete to be below five nanomoles per liter continuously over a period of time. at least 12 months before. to be declared eligible.

The old limit was 10 nanomoles.

Athletes must keep their testosterone levels below the five nanomole limit to maintain their eligibility to compete in the female category.

“Under the new regulations, a transgender athlete is no longer required to be recognized by law in her new gender, but must provide a signed statement that her gender identity is female,” a statement from the IAAF said.

Download the EWN app on your iOS or Android device.



[ad_2]